| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Williams Paul Anthony | SVP, Products Business | 300 PROFESSIONAL DRIVE, GAITHERSBURG | /s/ Richard S. Lindahl, Attorney-in-fact | 10 Feb 2026 | 0001961994 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | EBS | Common Stock | Disposed to Issuer | $94,513 | -8,655 | -10% | $10.92 | 77,216 | 06 Feb 2026 | Direct | F1 |
| transaction | EBS | Common Stock | Tax liability | $11,160 | -1,022 | -1.3% | $10.92 | 76,194 | 06 Feb 2026 | Direct | F2 |
| Id | Content |
|---|---|
| F1 | Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to both cumulative revenues and adjusted EBITDA as a percentage of total GAAP revenue calculated on a cumulative basis over the three-year period beginning January 1, 2023 and ending December 31, 2025. On February 06, 2026, the final certification date, the Compensation Committee certified the achievement of the 2023-2025 PSUs at a payout factor of 25% of target resulting in the actual award of 2,884 shares of common stock, which is less than the 11,539 shares previously reported on March 02, 2023 and June 09, 2023. |
| F2 | Represents shares of common stock withheld to pay taxes associated with vesting and settlement of restricted stock units |